Results 141 to 150 of about 233,135 (260)
Basal-Celled Carcinoma of the Palate [PDF]
openaire +2 more sources
Safe Use of Adrenaline in Cryosurgery for Eyelid Basal Cell Carcinoma Evaluated With Infrared Thermography. [PDF]
Wiktorin AHC +5 more
europepmc +1 more source
Advanced Materials for Biologics Delivery to Brain Tumors
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng +4 more
wiley +1 more source
Super giant basal cell carcinoma in the setting of neglect: A case report. [PDF]
Lim H +4 more
europepmc +1 more source
Spheroid‐On‐A‐Drop: A Modular Droplet Microfluidics Platform
The proposed Spheroid‐on‐a‐Drop platform represents a reproducible and tunable platform for the fabrication of biocompatible GelMA‐based microgels, able to support controlled 3D tumor spheroid culture. Its precise control over droplet dynamics and cell distribution paves the way for advanced applications in tissue modeling, drug screening, and ...
A. Fergola +8 more
wiley +1 more source
Metastatic Basal Cell Carcinoma With Unusual Molecular Genetics Findings. [PDF]
Al-Hail N +3 more
europepmc +1 more source
Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic
Zirui Zhang et al. reviewed the application and challenges of mobile nanomachines in interventional therapy. By converting exogenous energy, including chemical, magnetic, optical, and ultrasonic sources, into mechanical forces, micro/nanorobots (MNRs) enable precise actuation at unprecedented scales. Evolving far beyond traditional drug delivery, these
Zirui Zhang +5 more
wiley +1 more source
Basal Cell Carcinoma and Syringocystoadenoma Papilliferum Arising in Naevus Sebaceous-A Narrative Review. [PDF]
Dua Y, Miller C, Ramakrishnan A.
europepmc +1 more source
Anti‐PD‐1/PD‐L1 blockade has revolutionized cancer immunotherapy, but is ineffective against endocrine‐treated (i.e., Tamoxifen), relapsed ER+ breast cancer (BC) patients. This study provides insight into the sub‐optimal response of ER+BCs to anti‐PD‐1/PD‐L1 blockade – highlighting the induction of STING and the CEACAM1/TIM3 axis after chronic ...
Marvin Angelo E Aberin +20 more
wiley +1 more source
Primary periocular basal cell carcinoma: recurrence, risk factors and follow-up. [PDF]
Bezerra RG +4 more
europepmc +1 more source

